Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Debora Basile, Francesca Simionato, Lorenzo Calvetti, Alessandro Cappetta, Annalisa Pesavento, Marta Mongillo, Giandomenico Roviello, Gerardo Rosati, Gemma Rossi & Giuseppe Aprile. (2021) Comparing immunotherapies to other frequently used treatments of gastric cancer. Expert Review of Clinical Pharmacology 14:10, pages 1221-1232.
Read now
Read now
Meirong Liu, Chunhong Xu & Yingying Sun. (2019) Efficacy and safety of sodium cantharidinate and vitamin B6 injection for the treatment of digestive system neoplasms: a meta-analysis of randomized controlled trials. Drug Design, Development and Therapy 13, pages 183-203.
Read now
Read now
Yongxun Zhuan-Sun, Fengting Huang, Min Feng, Xinbao Zhao, Wenying Chen, Zhe Zhu & Shineng Zhang. (2017) Prognostic value of PD-L1 overexpression for pancreatic cancer: evidence from a meta-analysis. OncoTargets and Therapy 10, pages 5005-5012.
Read now
Read now
Articles from other publishers (15)
Danzan Mansorunov, Natalya Apanovich, Fatimat Kipkeeva, Maxim Nikulin, Olga Malikhova, Ivan Stilidi & Alexander Karpukhin. (2022) The Correlation of Ten Immune Checkpoint Gene Expressions and Their Association with Gastric Cancer Development. International Journal of Molecular Sciences 23:22, pages 13846.
Crossref
Crossref
Holger H. Göbel, Luitpold V.R. Distel, Thomas Aigner, Maike J. Büttner-Herold & Gerhard G. Grabenbauer. (2022) PD-1 and PD-L1 expression predict regression and prognosis following neoadjuvant radiochemotherapy of oesophageal adenocarcinoma. Clinical and Translational Radiation Oncology 34, pages 90-98.
Crossref
Crossref
Danzan Mansorunov, Natalya Apanovich, Pavel Apanovich, Fatimat Kipkeeva, Tatyana Muzaffarova, Anna Kuzevanova, Maxim Nikulin, Olga Malikhova & Alexander Karpukhin. (2021) Expression of Immune Checkpoints in Malignant Tumors: Therapy Targets and Biomarkers for the Gastric Cancer Prognosis. Diagnostics 11:12, pages 2370.
Crossref
Crossref
Chao Zhang, Shutao Zhao & Xudong Wang. (2021) Co-expression of CMTM6 and PD-L1: a novel prognostic indicator of gastric cancer. Cancer Cell International 21:1.
Crossref
Crossref
Jasmine Huynh, Kanishka Patel, Jun Gong, May Cho, Midhun Malla, Aparna Parikh & Samuel Klempner. (2021) Immunotherapy in Gastroesophageal Cancers: Current Evidence and Ongoing Trials. Current Treatment Options in Oncology 22:11.
Crossref
Crossref
Gao-Min Liu, Xu-Gang Li & Yao-Min Zhang. (2019) Prognostic role of PD-L1 for HCC patients after potentially curative resection: a meta-analysis. Cancer Cell International 19:1.
Crossref
Crossref
Toshihiko Doi, Satoru Iwasa, Kei Muro, Taroh Satoh, Shuichi Hironaka, Taito Esaki, Tomohiro Nishina, Hiroki Hara, Nozomu Machida, Yoshito Komatsu, Yasuhiro Shimada, Satoshi Otsu, Shin Shimizu & Morihiro Watanabe. (2018) Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer: the JAVELIN Solid Tumor JPN trial. Gastric Cancer 22:4, pages 817-827.
Crossref
Crossref
Giandomenico Roviello, Alberto D’Angelo, Daniele Generali, Matteo Pittacolo, Monica Ganzinelli, Giandomenica Iezzi, Nicolò de Manzini & Navid Sobhani. (2019) Avelumab in gastric cancer. Immunotherapy 11:9, pages 759-768.
Crossref
Crossref
X. Ni, X. Sun, D. Wang, Y. Chen, Y. Zhang, W. Li, L. Wang & J. Suo. (2018) The clinicopathological and prognostic value of programmed death-ligand 1 in colorectal cancer: a meta-analysis. Clinical and Translational Oncology 21:5, pages 674-686.
Crossref
Crossref
Ying Hu, Wanzhen Chen, Zhanpeng Yan, Jingxia Ma, Fangshi Zhu & Jiege Huo. (2019) Prognostic value of PD-L1 expression in patients with pancreatic cancer. Medicine 98:3, pages e14006.
Crossref
Crossref
Xiaoli Hu, Hailing Liu, Miaomiao Ye & Xueqiong Zhu. (2018) Prognostic value of microvessel density in cervical cancer. Cancer Cell International 18:1.
Crossref
Crossref
Hui Li, Jun‐Quan Xia, Fang‐Shi Zhu, Zhao‐Hong Xi, Cheng‐Yu Pan, Li‐Mei Gu & Yao‐Zhou Tian. (2018) LPS promotes the expression of PD‐L1 in gastric cancer cells through NF‐κB activation. Journal of Cellular Biochemistry 119:12, pages 9997-10004.
Crossref
Crossref
Ioannis Zerdes, Alexios Matikas, Jonas Bergh, George Z. Rassidakis & Theodoros Foukakis. (2018) Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations. Oncogene 37:34, pages 4639-4661.
Crossref
Crossref
Julien Taieb, Markus Moehler, Narikazu Boku, Jaffer A. Ajani, Eduardo Yañez Ruiz, Min-Hee Ryu, Silke Guenther, Vikram Chand & Yung-Jue Bang. (2018) Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives. Cancer Treatment Reviews 66, pages 104-113.
Crossref
Crossref
Christiane Thallinger, Thorsten Füreder, Matthias Preusser, Gerwin Heller, Leonhard Müllauer, Christoph Höller, Helmut Prosch, Natalija Frank, Rafal Swierzewski, Walter Berger, Ulrich Jäger & Christoph Zielinski. (2017) Review of cancer treatment with immune checkpoint inhibitors. Wiener klinische Wochenschrift 130:3-4, pages 85-91.
Crossref
Crossref